- Home
- Publications
- Publication Search
- Publication Details
Title
The mTOR pathway in hepatic malignancies
Authors
Keywords
-
Journal
HEPATOLOGY
Volume 58, Issue 2, Pages 810-818
Publisher
Wiley
Online
2013-02-13
DOI
10.1002/hep.26323
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Metformin Inhibits Growth of Hepatocellular Carcinoma Cells by Inducing Apoptosis Via Mitochondrion-mediated Pathway
- (2013) Yu Xiong et al. Asian Pacific Journal of Cancer Prevention
- Reprogramming of the MicroRNA Transcriptome Mediates Resistance to Rapamycin
- (2013) Hana Totary-Jain et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- MicroRNA-99a induces G1-phase cell cycle arrest and suppresses tumorigenicity in renal cell carcinoma
- (2012) Li Cui et al. BMC CANCER
- Metformin Prevents Liver Tumorigenesis by Inhibiting Pathways Driving Hepatic Lipogenesis
- (2012) K. Bhalla et al. Cancer Prevention Research
- eIF4E/4E-BP Ratio Predicts the Efficacy of mTOR Targeted Therapies
- (2012) T. Alain et al. CANCER RESEARCH
- Phase II study of sirolimus in treatment-naive patients with advanced hepatocellular carcinoma
- (2012) Thomas Decaens et al. DIGESTIVE AND LIVER DISEASE
- Rapamycin blocks hepatoblastoma growth in vitro and in vivo implicating new treatment options in high-risk patients
- (2012) Ferdinand Wagner et al. EUROPEAN JOURNAL OF CANCER
- Hepatic transforming growth factor beta gives rise to tumor-initiating cells and promotes liver cancer development
- (2012) Kun Wu et al. HEPATOLOGY
- In vitro and in vivo antitumoral action of metformin on hepatocellular carcinoma
- (2012) Zhan Qu et al. HEPATOLOGY RESEARCH
- Chronic Activation of mTOR Complex 1 Is Sufficient to Cause Hepatocellular Carcinoma in Mice
- (2012) S. Menon et al. Science Signaling
- mTOR Inhibitors Synergize on Regression, Reversal of Gene Expression, and Autophagy in Hepatocellular Carcinoma
- (2012) H. E. Thomas et al. Science Translational Medicine
- Thymosin-β4 (Tβ4) Blunts PDGF-Dependent Phosphorylation and Binding of AKT to Actin in Hepatic Stellate Cells
- (2011) Karina Reyes-Gordillo et al. AMERICAN JOURNAL OF PATHOLOGY
- Liver Transplantation for Hepatocellular Carcinoma: Five Steps to Prevent Recurrence
- (2011) C. Toso et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Phase 1/2 study of everolimus in advanced hepatocellular carcinoma
- (2011) Andrew X. Zhu et al. CANCER
- mTOR complex 2 signaling and functions
- (2011) Won Jun Oh et al. CELL CYCLE
- Osteopontin, an oxidant stress sensitive cytokine, up-regulates collagen-I via integrin αVβ3 engagement and PI3K/pAkt/NFκB signaling
- (2011) Raquel Urtasun et al. HEPATOLOGY
- l-Tryptophan-mediated Enhancement of Susceptibility to Nonalcoholic Fatty Liver Disease Is Dependent on the Mammalian Target of Rapamycin
- (2011) Yosuke Osawa et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- m-TOR inhibitors: What role in liver transplantation?
- (2011) Toshiyasu Kawahara et al. JOURNAL OF HEPATOLOGY
- Dual targeting of mTORC1/C2 complexes enhances histone deacetylase inhibitor-mediated anti-tumor efficacy in primary HCC cancer in vitro and in vivo
- (2011) Huanjie Shao et al. JOURNAL OF HEPATOLOGY
- PKI-587 and Sorafenib Targeting PI3K/AKT/mTOR and Ras/Raf/MAPK Pathways Synergistically Inhibit HCC Cell Proliferation
- (2011) Roberto Gedaly et al. JOURNAL OF SURGICAL RESEARCH
- Sirolimus-based immunosuppression in liver transplantation for hepatocellular carcinoma: A meta-analysis
- (2011) Wenhua Liang et al. LIVER TRANSPLANTATION
- Efficacy and safety of sorafenib in combination with mammalian target of rapamycin inhibitors for recurrent hepatocellular carcinoma after liver transplantation
- (2011) Carlos Gomez-Martin et al. LIVER TRANSPLANTATION
- The expression of phospho-AKT1 and phospho-MTOR is associated with a favorable prognosis independent of PTEN expression in intrahepatic cholangiocarcinomas
- (2011) Dakeun Lee et al. MODERN PATHOLOGY
- Rapamycin passes the torch: a new generation of mTOR inhibitors
- (2011) Don Benjamin et al. NATURE REVIEWS DRUG DISCOVERY
- Common toxicities of mammalian target of rapamycin inhibitors
- (2011) Scott A. Soefje et al. Targeted Oncology
- Array comparative genomic hybridization identifies novel potential therapeutic targets in cholangiocarcinoma
- (2011) Siobhan C. McKay et al. HPB
- Increased Lipogenesis, Induced by AKT-mTORC1-RPS6 Signaling, Promotes Development of Human Hepatocellular Carcinoma
- (2010) Diego F. Calvisi et al. GASTROENTEROLOGY
- Activation of LKB1-Akt pathway independent of phosphoinositide 3-kinase plays a critical role in the proliferation of hepatocellular carcinoma from nonalcoholic steatohepatitis
- (2010) Nuria Martínez-López et al. HEPATOLOGY
- Potent antifibrotic activity of mTOR inhibitors sirolimus and everolimus but not of cyclosporine A and tacrolimus in experimental liver fibrosis
- (2010) Eleonora Patsenker et al. JOURNAL OF HEPATOLOGY
- Metformin and reduced risk of hepatocellular carcinoma in diabetic patients with chronic liver disease
- (2010) Valter Donadon et al. LIVER INTERNATIONAL
- Activation of Phosphatidylinositol-3'-kinase/AKT Signaling Is Essential in Hepatoblastoma Survival
- (2009) W. Hartmann et al. CLINICAL CANCER RESEARCH
- The Expression of Phospho-AKT, Phospho-mTOR, and PTEN in Extrahepatic Cholangiocarcinoma
- (2009) J.-Y. Chung et al. CLINICAL CANCER RESEARCH
- S6K1 deficiency protects against apoptosis in hepatocytes
- (2009) Águeda González-Rodriguez et al. HEPATOLOGY
- Rapamycin delays tumor development in murine livers by inhibiting proliferation of hepatocytes with DNA damage
- (2009) Laura Elisa Buitrago-Molina et al. HEPATOLOGY
- mTOR signaling at a glance
- (2009) M. Laplante et al. JOURNAL OF CELL SCIENCE
- miR-221 overexpression contributes to liver tumorigenesis
- (2009) P. Pineau et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- SREBP Activity Is Regulated by mTORC1 and Contributes to Akt-Dependent Cell Growth
- (2008) Thomas Porstmann et al. Cell Metabolism
- Pivotal Role of mTOR Signaling in Hepatocellular Carcinoma
- (2008) Augusto Villanueva et al. GASTROENTEROLOGY
- The survival pathways phosphatidylinositol-3 kinase (PI3-K)/phosphoinositide-dependent protein kinase 1 (PDK1)/Akt modulate liver regeneration through hepatocyte size rather than proliferation
- (2008) Sanae Haga et al. HEPATOLOGY
- Effects of the mTOR inhibitor sirolimus in patients with hepatocellular and cholangiocellular cancer
- (2008) Magnus Rizell et al. International Journal of Clinical Oncology
- AMPK Phosphorylation of Raptor Mediates a Metabolic Checkpoint
- (2008) Dana M. Gwinn et al. MOLECULAR CELL
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now